BRPI0821483A2 - Tratamento de doença cardíaca usando beta-bloqueadores - Google Patents

Tratamento de doença cardíaca usando beta-bloqueadores

Info

Publication number
BRPI0821483A2
BRPI0821483A2 BRPI0821483-2A BRPI0821483A BRPI0821483A2 BR PI0821483 A2 BRPI0821483 A2 BR PI0821483A2 BR PI0821483 A BRPI0821483 A BR PI0821483A BR PI0821483 A2 BRPI0821483 A2 BR PI0821483A2
Authority
BR
Brazil
Prior art keywords
heart disease
disease treatment
beta blockers
blockers
beta
Prior art date
Application number
BRPI0821483-2A
Other languages
English (en)
Inventor
Gerald Beddies
Axel Schmidt
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of BRPI0821483A2 publication Critical patent/BRPI0821483A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0821483-2A 2007-12-27 2008-12-19 Tratamento de doença cardíaca usando beta-bloqueadores BRPI0821483A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1689107P 2007-12-27 2007-12-27
PCT/EP2008/010892 WO2009083177A1 (en) 2007-12-27 2008-12-19 TREATMENT OF HEART DISEASE USING β-BLOCKERS

Publications (1)

Publication Number Publication Date
BRPI0821483A2 true BRPI0821483A2 (pt) 2015-06-16

Family

ID=40456577

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821483-2A BRPI0821483A2 (pt) 2007-12-27 2008-12-19 Tratamento de doença cardíaca usando beta-bloqueadores

Country Status (19)

Country Link
US (1) US20100305213A1 (pt)
EP (1) EP2234609A1 (pt)
JP (1) JP2011507918A (pt)
KR (1) KR20100102640A (pt)
CN (1) CN101909612A (pt)
AU (1) AU2008342250A1 (pt)
BR (1) BRPI0821483A2 (pt)
CA (1) CA2710665A1 (pt)
CO (1) CO6300936A2 (pt)
CR (1) CR11501A (pt)
EC (1) ECSP10010249A (pt)
IL (1) IL205870A0 (pt)
MX (1) MX2010006443A (pt)
NI (1) NI201000096A (pt)
RU (1) RU2010131022A (pt)
SV (1) SV2010003595A (pt)
TW (1) TW200942227A (pt)
WO (1) WO2009083177A1 (pt)
ZA (1) ZA201003867B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113148A1 (zh) * 2012-01-30 2013-08-08 Lin Shuguang β3肾上腺素受体阻滞剂的抗肿瘤用途
HUE055974T2 (hu) 2015-03-03 2022-01-28 Saniona As Tesofensine és metoprolol kombinációs készítmény
US11235029B2 (en) 2017-03-09 2022-02-01 Temple University-Of The Commonwealth System of Higher Methods for treating heart failure with a TRKB agonist
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
CN110269938A (zh) * 2019-06-27 2019-09-24 山东省眼科研究所 一种减轻铜绿假单胞菌性角膜炎症的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung

Also Published As

Publication number Publication date
CR11501A (es) 2010-11-12
ZA201003867B (en) 2011-08-31
SV2010003595A (es) 2011-01-14
CO6300936A2 (es) 2011-07-21
WO2009083177A1 (en) 2009-07-09
CN101909612A (zh) 2010-12-08
ECSP10010249A (es) 2010-07-30
TW200942227A (en) 2009-10-16
CA2710665A1 (en) 2009-07-09
JP2011507918A (ja) 2011-03-10
MX2010006443A (es) 2010-09-03
US20100305213A1 (en) 2010-12-02
EP2234609A1 (en) 2010-10-06
AU2008342250A1 (en) 2009-07-09
IL205870A0 (en) 2010-11-30
NI201000096A (es) 2011-03-23
KR20100102640A (ko) 2010-09-24
RU2010131022A (ru) 2012-02-10

Similar Documents

Publication Publication Date Title
BRPI0917567A2 (pt) tratamento de doença respiratória
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
HUE071237T2 (hu) Fabry-kór kezelési lehetõségei
BRPI0917432A2 (pt) aparelho de assistência ao coraçâo
EP2296593A4 (en) MEDICAL HEAD COVER
EP2327448A4 (en) defibrillation catheter
EP2442709C0 (en) BODY-WORN SPHYGMO-OXIMETER
EP2231061A4 (en) Implantable prosthesis
EP2138200A4 (en) SUCTION CATHETER OF A THROMBUS
BRPI0818311A2 (pt) manipulador médico
EP2479575A4 (en) BLOOD GLUCOSE METER
EP2213325A4 (en) CATHETER
DE602008004368D1 (de) Endoskop-Behandlungswerkzeug
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK1987765T3 (da) Oximeter
ATE494839T1 (de) Gewebeentnahme
IL214674A (en) Paediatric solutions comprising a beta-blocker
FR2913196B1 (fr) Implant oculaire accomodatif
BRPI0810559A2 (pt) Macadores de doenças
DK2173831T3 (da) Brøndbehandling
BRPI0821652A2 (pt) tratamento de biocombustíveis
EP3381471C0 (en) PAIN TREATMENT
EP2216067A4 (en) CATHETER
BRPI0815683A2 (pt) Conjunto de tratamento de vaso sanitário
BRPI0820449A2 (pt) Conjunto de implante médico interfaceado

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.